• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·300244.SZ
Share

Dian Diagnostics Group Co.,Ltd. Stocks

CN¥ 21.36Last Updated 26.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 1.60B

CN¥ 21.36
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Slightly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of medical diagnostic services within China. The company delivers comprehensive diagnostic solutions to a broad spectrum of healthcare organizations, including general and specialized hospitals, community health centers, township clinics, physical examination facilities, and disease prevention and control agencies. Supporting its extensive operations, Dian Diagnostics manages a global network of 40 advanced chain laboratories. Beyond its core diagnostic offerings, the company is also deeply involved in the research, development, and manufacturing of in vitro diagnostic reagents, along with associated equipment and consumables. Furthermore, it plays a crucial role in the medical supply chain, facilitating the provision of various products such as medical equipment, pharmaceuticals, clinical samples, biological products, finished blood products, live animals, chemical compounds, and diagnostic reagents. Dian Diagnostics also specializes in comprehensive cold chain logistics, which includes transportation, warehousing, product sales, and technical support services for temperature-sensitive medical goods. Founded in 2001, the company is headquartered in Hangzhou, China. It adopted its current name, Dian Diagnostics Group Co.,Ltd., in November 2017, having previously operated as Zhejiang DIAN Diagnostics Co., Ltd.

Company Valuation

Slightly undervalued
5/7

Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, underpriced

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 300244.SZ is 18.3 and suggests 15.4% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 01:51

Anthropic Disclosed Its Reliance on Google, Amazon, and Microsoft Ahead of Its IPO. What Is the Risk?

27.10.2026 00:38

Microsoft is cutting costs: 60,000 employees have been offered voluntary separation

27.10.2026 00:18

"If the bubble bursts, it will all start with debt": How the problems of the neo-claws threaten the S&P 500

26.10.2026 23:40

Buyers of the foldable iPhone have complained about screen damage. How does this affect the stock price?

26.10.2026 23:02

One of Wall Street’s biggest bulls drops overweight call on stocks ahead of midterms

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026